Bicara Therapeutics Inc (BCAX)

NASDAQ

$27.15

Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. The company is headquartered in Boston, Massachusetts.

Website: https://www.bicara.com

Sector:

Healthcare

Industry:

Biotechnology

68 analysts

Buy

Target: $31.46 (+15.87%)

Market Cap

$1.84B

Free Cash Flow Yield

-6.33%

Beta (5Y)

1.40

Price Chart

Adjust inflation

Log

Valuation

Market Cap$1.84B

P/B3.59

Profitability

EBITDA-$174M

EPS-$2.69

Financial Health

Free Cash Flow Yield-6.33%

Growth & Risk

Beta (5Y)1.40

Sharpe Ratio1.64